Plain-English translation of NCT06353646 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new treatment approach for people with pancreatic cancer who have had surgery to remove their tumor. The trial combines , a personalized cancer vaccine designed specifically for each patient's tumor, with immune-boosting medications and . The goal is to see whether this combination helps prevent cancer from coming back.
Pancreatic cancer is aggressive and often returns after surgery, even when the tumor is completely removed. This medication aims to train your immune system to recognize and fight any remaining cancer cells that standard treatments might miss, potentially improving long-term survival.
You likely qualify if…
You likely don't qualify if…
You would receive the personalized cancer vaccine as a series of injections combined with standard and immune-boosting medications. The trial involves regular visits to the research center for treatment administration, blood tests, and monitoring for side effects. The exact schedule and duration of treatment would be explained by the research team, but typically involves several months of active treatment followed by monitoring visits to watch for cancer recurrence.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China